Atovax®
PHARMACEUTICAL FORM:
Film-coated tablet
ATC class:
Antimicrobial agents for systemic use. Quinolone group antibacterial agents
Active substance:
Moxifloxacin
Composition:
1 film-coated tablet contains moxifloxacin hydrochloride equivalent to 400 mg moxifloxacin
Indications for use:
Treatment of the following bacterial infections caused by microorganisms susceptible to moxifloxacin in patients aged 18 years and older.
Acute bacterial sinusitis.
Exacerbation of chronic obstructive pulmonary disease including bronchitis.
Community-acquired pneumonia, except severe community-acquired pneumonia.
Mild to moderate pelvic inflammatory diseases (including infections of the female upper reproductive tract, including salpingitis and endometritis), not associated with tubo-ovarian or pelvic abscess.
Moxifloxacin in tablet form is not recommended for use as monotherapy of mild to moderate pelvic inflammatory disease but may be used in combination with other appropriate antibacterial agents (e.g. cephalosporins) due to increasing moxifloxacin resistance of Neisseria gonorrhoeae, unless moxifloxacin-resistant Neisseria gonorrhoeae can be excluded.
Moxifloxacin in tablet form may also be used to complete a course of treatment in which the initial treatment with moxifloxacin in parenteral form was effective and was prescribed for the following indications: community-acquired pneumonia; complicated skin and skin structure infections.
